EXACT SCIENCES THRIVE LLC

Medtech · Private

PapGene, a genetic cytology test that detects ovarian and endometrial cancers from Pap specimens using massively parallel sequencing to identify cancer-causative DNA mutations

Grants
$84K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
1
0 granted · 1 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase II · Genetic Cytology for Ovarian and Endometrial Cancer Screening$83,802
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
662Vibrato Medical, Inc.——
663Sight Sciences, Inc.—$102M
664Microsurgical Innovations Inc——
665EXACT SCIENCES THRIVE LLC——
666ACTIV SITTING, INC.——
667CHISQUARE BIOIMAGING, LLC——
668STAR VOLTAIC LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 1
  • Barcoded Molecular Standardsapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.